The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhysiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 1.10
Ask: 1.40
Change: 0.00 (0.00%)
Spread: 0.30 (27.273%)
Open: 1.25
High: 1.25
Low: 1.25
Prev. Close: 1.25
PYC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Physiomics secures contract with University of Sheffield

Mon, 19th Feb 2024 10:16

(Sharecast News) - Data science firm Physiomics has been chosen by the University of Sheffield to support a grant-funded project focused on an insect model of cancer treatment.

Physiomics said on Monday that the contract was valued at £45,000 and will begin in the second half of the year. The group added that the work was in support of one of seven cancer-focussed projects recently announced by the University, all of which will be funded by Yorkshire Cancer Research.

The AIM-listed group added that the work follows on from a pilot project with the University, funded by UK Research and Innovation's Higher Education Innovation Funding scheme, with the project focussed on the development of an insect model of cancer that could be used to screen new drugs prior to pre-clinical testing in more traditional models of cancer and has a particular focus on the prediction of metastasis.

Physiomics' role will be to create mathematical models based on experimental data and to explore the relationship between the effect of drugs in these models, established models, and humans. Physiomics will also provide advice and guidance on the possible commercialisation of the technology.

As of 1010 GMT, Physiomics shares were up 3.7% at 1.40p.

Reporting by Iain Gilbert at Sharecast.com

More News
21 Jun 2018 09:17

Physiomics Expects Annual Loss To Be "Materially Reduced"

LONDON (Alliance News) - Physiomics PLC said Thursday it is trading "ahead of market expectations" for its financial year to the end of June.The company, which provides technology

Read more
23 May 2018 12:44

Physiomics Raises GBP525,000 Via Placing For Expansion (ALLISS)

LONDON (Alliance News) - Physiomics PLC on Wednesday said that it raised GBP525,000 through share placing to grow the business and expand its client base.The biotechnology company issued at

Read more
14 Mar 2018 12:42

Physiomics Awarded New GBP68,000 Innovate UK Grant For Cancer Project

LONDON (Alliance News) - Physiomics PLC said Wednesday it has been awarded a new Innovate UK Grant worth GBP68,000 for a prostate cancer -

Read more
12 Mar 2018 11:34

Physiomics Successfully Completes Innovate UK Grant Project

LONDON (Alliance News) - Physiomics PLC said Monday it has successfully completed the Innovate UK grant cancer treatment project, receiving in funding the

Read more
11 Jan 2017 14:22

Physiomics makes 'good progress' towards objectives

(ShareCast News) - Physiomics announced on Wednesday that it is making good progress towards the strategic objectives announced in its most recent full year results, posted on 27 October 2016. The AIM-traded firm announced an initial payment by Sareum on 5 December, for modelling carried out by the

Read more
6 Jan 2017 12:28

Physiomics receives Innovate UK grant for cancer treatment project

(ShareCast News) - Systems biology company Physiomics confirmed on Friday that is has been awarded the Innovate UK grant as part of its Biomedical Catalyst 2016 Feasibility Study Competition that was the subject of a provisional announcement on 22 November. The AIM-traded firm said the proposed proj

Read more
22 Nov 2016 10:57

Physiomics Provisionally Awarded Innovate UK Grant

Read more
27 Oct 2016 14:15

Physiomics Annual Loss Widens After Incurring Additional Costs

Read more
21 Sep 2016 10:43

Physiomics raises £555,000 after shelving BioMoti acquisition

(ShareCast News) - AIM listed Physiomics has called off its BioMoti acquisition after investors instead backed plans to develop its modelling and simulation business with a £555,000 discounted fundraising. Physiomics, which develops software to help drug companies predict and understand cancer drug

Read more
16 May 2016 07:26

Physiomics Signs Two Extensions On Virtual Tumour Project

Read more
3 May 2016 07:39

Physiomics Appoints Andrew Clayden As Part-Time Head Of Finance

Read more
18 Apr 2016 13:41

James Millen takes the helm at Physiomics

(ShareCast News) - Physiomics had a new man at the helm on Monday, confirming Dr James Millen was taking the reins as CEO with immediate effect. The AIM-traded company said Millen, known as Jim, brought experience of drug development and licensing deals in global pharmaceutical companies with him.

Read more
18 Apr 2016 08:51

Physiomics Names James Millen As Chief Executive

Read more
4 Apr 2016 11:24

Physiomics Inks Further Contract With Speciality Pharma Customer

Read more
31 Mar 2016 10:11

Physiomics To Buy BioMoti And Raise Funds As CEO Steps Down (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.